Evidence map›Paper›PMID 27429202›Full record

ArticlePediatric research2016

Increased EHEC survival and virulence gene expression indicate an enhanced pathogenicity upon simulated pediatric gastrointestinal conditions.

Charlène Roussel, Charlotte Cordonnier, Wessam Galia, Olivier Le Goff, Jonathan Thévenot, Sandrine Chalancon, Monique Alric, Delphine Thevenot-Sergentet, Francoise Leriche, Tom Van de Wiele and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Modulation of EnterohaemorrhagicMicroorganisms · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Charlène RousselEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Charlotte CordonnierEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Wessam GaliaEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Olivier Le GoffEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Jonathan ThévenotEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Sandrine ChalanconEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Monique AlricEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Delphine Thevenot-SergentetUMR 5557 Ecologie Microbienne, Research Group on Bacterial Opportunistic Pathogens and Environment, CNRS, VetAgro Sup and Université de Lyon, Lyon, France.
Francoise LericheUnité CALYTISS, VetAgro Sup, Lempdes, France.
Tom Van de WieleCMet, Center for Microbial Ecology and Technology, Ghent University, Ghent, Belgium.
Valérie LivrelliM2iSH, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte UMR INSERM/Université d'Auvergne, Université d'Auvergne, Clermont-Ferrand, France.
Stéphanie Blanquet-DiotEA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Université d'Auvergne, Clermont-Ferrand, France.
Centre National de la Recherche Scientifique · FRGhent University · BEInserm · FRMicrobe, Intestine, Inflammation and Host Susceptibility · FRVetAgro Sup · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnterohemorrhagic Escherichia coli (EHEC) are major foodborne pathogens that constitute a serious public health threat, mainly in young children. Shiga toxins (Stx) are the main virulence determinants of EHEC pathogenesis but adhesins like intimin (eae) and Long polar fimbriae (Lpf) also contribute to infection. The TNO GastroIntestinal Model (TIM) was used for a comparative study of EHEC O157:H7 survival and virulence under adult and child digestive conditions.

methodsSurvival kinetics in the in vitro digestive tract were determined by plating while bacterial viability was assessed by flow cytometry analysis. Expression of stx, eae, and lpf genes was followed by reverse transcriptase-quantitative PCR (RT-qPCR) and Stx production was measured by ELISA (enzyme-linked immunosorbent assay).

resultsUpon gastrointestinal passage, a higher amount of viable cells was found in the simulated ileal effluents of children compared to that of adults (with 34 and 6% of viable cells, respectively). Expression levels of virulence genes were up to 125-fold higher in children. Stx was detected only in child ileal effluents.

conclusionDifferences in digestive physicochemical parameters may partially explain why children are more susceptible to EHEC infection than adults. Such data are essential for a full understanding of EHEC pathogenesis and would help in designing novel therapeutic approaches.

Indexed as

Adhesins, BacterialAdultChildEnterohemorrhagic Escherichia coliEscherichia coli InfectionsEscherichia coli O157Flow CytometryGastric MucosaHumansIntestine, SmallKineticsModels, BiologicalShiga ToxinVirulenceVirulence FactorsAdhesins, BacterialShiga ToxinVirulence Factors

Identifiers

PMID27429202
OpenAlexW2504821778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.